Risk of hepatobiliary cancer after solid organ transplant in the United States.
about
De novo malignancy in organ transplant recipients in Taiwan: a nationwide cohort population studyCancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan.Standardised incidence ratios (SIRs) for cancer after renal transplant in systemic lupus erythematosus (SLE) and non-SLE recipients.Risk of Colorectal Cancer After Solid Organ Transplantation in the United States.Selection and use of immunosuppressive therapies after liver transplantation: current German practice.Decreasing incidence of cancer after liver transplantation-A Nordic population-based study over 3 decades.
P2860
Risk of hepatobiliary cancer after solid organ transplant in the United States.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Risk of hepatobiliary cancer after solid organ transplant in the United States.
@ast
Risk of hepatobiliary cancer after solid organ transplant in the United States.
@en
type
label
Risk of hepatobiliary cancer after solid organ transplant in the United States.
@ast
Risk of hepatobiliary cancer after solid organ transplant in the United States.
@en
prefLabel
Risk of hepatobiliary cancer after solid organ transplant in the United States.
@ast
Risk of hepatobiliary cancer after solid organ transplant in the United States.
@en
P2093
P2860
P1476
Risk of hepatobiliary cancer after solid organ transplant in the United States.
@en
P2093
Eric A Engels
Jill Koshiol
Karen Pawlish
Katherine A McGlynn
Marc T Goodman
P2860
P304
P356
10.1016/J.CGH.2013.12.018
P407
P577
2013-12-19T00:00:00Z